Estrogen Receptor Beta Shown to Act as Tumor Suppressor in Patients with Inflammatory Breast Cancer
Pharmacy Times,
Estrogen receptor beta (ERβ) was shown to act as a mediator of estrogen signaling and a tumor suppressor in inflammatory breast…
Estrogen receptor beta (ERβ) was shown to act as a mediator of estrogen signaling and a tumor suppressor in inflammatory breast…
The prognosis of recurrent/metastatic SS remains poor, highlighting the need for a novel therapeutic strategy.
The mechanisms underlying the observed effects of progesterone on breast cancer outcomes are unclear.
[...] we demonstrated that the combination of Nerofe and DOX exerts a synergistic effect during mCRC treatment [...]